Sunesis Announces Data of Ongoing Vosaroxin Study at ASCO By: Benzinga via Benzinga April 22, 2014 at 07:09 AM EDT Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that updated data from the ongoing Phase 1b/2 University of Texas MD ... Read More >>